Evaluation of saffron effect on intraocular pressure in glaucoma patients

The Ocular Hypotensive Effect of Saffron Extract in Primary Open Angle Glaucoma: a Pilot Study

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT201201278832N1

Enrollment

Registered

2012-12-19

Start date

2012-02-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

primary open angle glaucoma. Primary open-angle glaucoma

Interventions

Intervention 1: placebo capsule daily. Intervention 2: saffron capsule daily( 30 mg).

Treatment - Drugs

placebo capsule daily

saffron capsule daily( 30 mg)

Eligibility

Sex/Gender

All

Age

50 Years to No maximum

Inclusion criteria

Inclusion criteria: inclusion criteria :open angle glaucoma; age >50 exclusioncriteria: angle closure glaucoma; systemic componding medication

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Intraocular pressure. Timepoint: baseline,7th,21th and 28th day after 1 month wash-out. Method of measurement: goldmann tonometery.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Hossein Jabbarpoor Bonyadi

Gonabad University of Medical Sciences

drbonyadi@gmu.ac.ir+98 53 3722 9012

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Mar 19, 2026